Imatinib and cardiac failure in idiopathic hypereosinophilic syndrome.
Pieri
Lisa
L
Bosi
Alberto
A
Vannucchi
Alessandro M
AM
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001549:Benzamides; D004452:Echocardiography / Q000379:methods; D004562:Electrocardiography / Q000379:methods; D004804:Eosinophils; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000503:physiopathology; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D000068877:Imatinib Mesylate; D007958:Leukocyte Count; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage* / Q000009:adverse effects*; D014336:Troponin / Q000097:blood
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D014336:Troponin; D000068877:Imatinib Mesylate